Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15127983rdf:typepubmed:Citationlld:pubmed
pubmed-article:15127983lifeskim:mentionsumls-concept:C0038325lld:lifeskim
pubmed-article:15127983lifeskim:mentionsumls-concept:C0085932lld:lifeskim
pubmed-article:15127983lifeskim:mentionsumls-concept:C0020835lld:lifeskim
pubmed-article:15127983lifeskim:mentionsumls-concept:C0596473lld:lifeskim
pubmed-article:15127983lifeskim:mentionsumls-concept:C0205132lld:lifeskim
pubmed-article:15127983lifeskim:mentionsumls-concept:C1554080lld:lifeskim
pubmed-article:15127983lifeskim:mentionsumls-concept:C1706198lld:lifeskim
pubmed-article:15127983pubmed:issue4lld:pubmed
pubmed-article:15127983pubmed:dateCreated2004-5-6lld:pubmed
pubmed-article:15127983pubmed:abstractTextWith the emergence of highly resistant beta-lactam gram-positive organisms, vancomycin hydrochloride usage has increased considerably. Consequently, adverse drug reactions, including unfavorable cutaneous events, have also increased. Important adverse skin reactions are linear IgA bullous dermatosis (LABD) and Stevens-Johnson syndrome (SJS). These blistering disorders can have clinical manifestations that are difficult to distinguish; however, it is important to make the distinction because treatment and prognosis are different.lld:pubmed
pubmed-article:15127983pubmed:languageenglld:pubmed
pubmed-article:15127983pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15127983pubmed:citationSubsetIMlld:pubmed
pubmed-article:15127983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15127983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15127983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15127983pubmed:statusMEDLINElld:pubmed
pubmed-article:15127983pubmed:monthAprlld:pubmed
pubmed-article:15127983pubmed:issn0098-6151lld:pubmed
pubmed-article:15127983pubmed:authorpubmed-author:CraigTimothy...lld:pubmed
pubmed-article:15127983pubmed:authorpubmed-author:JonesDouglas...lld:pubmed
pubmed-article:15127983pubmed:authorpubmed-author:ToddMichaelMlld:pubmed
pubmed-article:15127983pubmed:issnTypePrintlld:pubmed
pubmed-article:15127983pubmed:volume104lld:pubmed
pubmed-article:15127983pubmed:ownerNLMlld:pubmed
pubmed-article:15127983pubmed:authorsCompleteYlld:pubmed
pubmed-article:15127983pubmed:pagination157-63lld:pubmed
pubmed-article:15127983pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:15127983pubmed:meshHeadingpubmed-meshheading:15127983...lld:pubmed
pubmed-article:15127983pubmed:meshHeadingpubmed-meshheading:15127983...lld:pubmed
pubmed-article:15127983pubmed:meshHeadingpubmed-meshheading:15127983...lld:pubmed
pubmed-article:15127983pubmed:meshHeadingpubmed-meshheading:15127983...lld:pubmed
pubmed-article:15127983pubmed:meshHeadingpubmed-meshheading:15127983...lld:pubmed
pubmed-article:15127983pubmed:meshHeadingpubmed-meshheading:15127983...lld:pubmed
pubmed-article:15127983pubmed:meshHeadingpubmed-meshheading:15127983...lld:pubmed
pubmed-article:15127983pubmed:meshHeadingpubmed-meshheading:15127983...lld:pubmed
pubmed-article:15127983pubmed:meshHeadingpubmed-meshheading:15127983...lld:pubmed
pubmed-article:15127983pubmed:meshHeadingpubmed-meshheading:15127983...lld:pubmed
pubmed-article:15127983pubmed:year2004lld:pubmed
pubmed-article:15127983pubmed:articleTitleEarly diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome.lld:pubmed
pubmed-article:15127983pubmed:affiliationMilton S. Hershey Medical Center, Pennsylvania State University, Hershey, PA 17033-0850, USA.lld:pubmed
pubmed-article:15127983pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15127983pubmed:publicationTypeReviewlld:pubmed